SuryaPrakashBhattMDMSPH

Asthma & COPD, Pulmonary Rehabilitation

Professor of Medicine, University of Alabama at Birmingham

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Medical Director, Pulmonary Function and Exercise Physiology Lab
Medical Director, Pulmonary Rehabilitation/Telehealth Pulmonary Rehabilitation
Director, UAB Lung Imaging Lab

University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
St Luke's University HospitalResidency, Internal Medicine, 2006 - 2009
Mysore Medical CollegeClass of 2001

PubMed

4 citations
Computed tomography quantification of tracheal abnormalities in COPD and their influence on airflow limitation
Leticia Gallardo Estrella, Esther Pompe, Jan-Martin Kuhnigk, David A. Lynch, Surya P. Bhatt
Medical Physics. 2017-05-22
81 citations
Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians
Manik Lal Thakur, Sanjay Sharma, Atin Kumar, Surya P. Bhatt, Kalpana Luthra
Atherosclerosis. 2012-08-01
44 citations
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene
J. Michael Wells, Margaret M. Parker, Robert A. Oster, Russell P. Bowler, Mark T. Dransfield
JCI Insight. 2018-11-15

Dupilumab Improves Quality of Life for COPD PatientsOctober 10th, 2024
Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
Join now to see all